Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Summary

Official

Protecting Our Pharmaceutical Supply Chain from China Act of 2020 This bill requires the federal government to maintain a registry of certain foreign-sourced drugs, prohibits federal health care programs from purchasing drugs containing Chinese ingredients, requires drugs to be labeled for country of origin, and offers domestic manufacturing facility tax incentives.

How would you vote on this bill?

Yes No

Bill Progress

Committee is reviewing, marking up, or holding hearings on the bill

Introduced(4/10/20)

Committee

Passed House

Passed Senate

President

Law